These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3009597)

  • 1. Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients.
    Carmina E; Rosato F; Jannì A
    J Endocrinol Invest; 1986 Feb; 9(1):5-9. PubMed ID: 3009597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of plasma adrenocorticotropin in polycystic ovary disease.
    Chang RJ; Mandel FP; Wolfsen AR; Judd HL
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1265-7. PubMed ID: 6281296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human pituitary luteinizing hormone administration on plasma levels of dehydroepiandrosterone, androstenediol and their sulphates and testosterone in women with secondary amenorrhoea.
    Sirinathsinghji DJ; Mills IH
    J Endocrinol; 1983 Aug; 98(2):201-10. PubMed ID: 6223967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset 3 beta-ol-hydroxysteroid-dehydrogenase deficiency: prevalence, clinical presentation and endocrine pattern.
    Carmina E; Rosato F; Caputo A; Janní A
    Acta Eur Fertil; 1985; 16(6):427-30. PubMed ID: 3008481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does adrenal cortex influence prolactin secretion? Evaluation in hirsute women.
    Tafaro E; Natale R; Vitale F; Giorgino R
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1872-6. PubMed ID: 6322820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
    Van den Berghe G; de Zegher F; Wouters P; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):457-63. PubMed ID: 7586621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone free index correlates best with dehydroepiandrosterone sulfate.
    Haning RV; Carlson IH; Shapiro SS; Nolten WE
    Fertil Steril; 1981 Dec; 36(6):757-65. PubMed ID: 6458518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hyperstimulation augments adrenal dehydroepiandrosterone sulfate secretion.
    Casson PR; Kristiansen SB; Umstot E; Carson SA; Buster JE
    Fertil Steril; 1996 May; 65(5):950-3. PubMed ID: 8612855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
    Lobo RA; Paul WL; Goebelsmann U
    Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and morphological maturation of the fetal and neonatal adrenal cortex in baboons.
    Ducsay CA; Hess DL; McClellan MC; Novy MJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):385-95. PubMed ID: 1649841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low dehydroepiandrosterone sulfate levels.
    Ayers JW
    Fertil Steril; 1982 May; 37(5):645-9. PubMed ID: 6281086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients.
    Carmina E; Lobo RA
    Gynecol Endocrinol; 1990 Dec; 4(4):225-32. PubMed ID: 1964538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.